{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:14:11Z","timestamp":1784139251773,"version":"3.55.0"},"reference-count":46,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1700,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1111\/j.1365-2567.2010.03377.x","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T16:32:33Z","timestamp":1294245153000},"page":"410-420","source":"Crossref","is-referenced-by-count":49,"title":["Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expressionof interleukin-32 controls the expression of the humanpapillomavirus oncogene"],"prefix":"10.1111","volume":"132","author":[{"given":"Sojung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Woo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinman","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JongSup","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SurNie","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinTae","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,5]]},"reference":[{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB1|cit1","first-page":"3","article-title":"Epidemiology of cervical cancer-overview","volume":"119","author":"Brinton","year":"1992","journal-title":"IARC Sci Publ"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2008.11.1928","article-title":"HPV and cervical cancer: updates on an established relationship","volume":"120","author":"Subramanya","year":"2008","journal-title":"Postgrad Med"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00292-008-1072-5","article-title":"Human papillomavirus infection. Pathology and molecular pathology","volume":"29","author":"Sotlar","year":"2008","journal-title":"Pathologe"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1042\/BST0351456","article-title":"HPV: from infection to cancer","volume":"35","author":"Stanley","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/carcin\/bgp066","article-title":"Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein","volume":"30","author":"Kim","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB6|cit6","first-page":"53","article-title":"Mechanisms of high-risk human papillomavirus-induced cervical carcinogenesis","volume":"67","author":"Narisawa-Saito","year":"2009","journal-title":"Nippon Rinsho"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/MCB.13.10.6537","article-title":"Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex","volume":"13","author":"Arroyo","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rmv.605","article-title":"Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins","volume":"19","author":"Yugawa","year":"2009","journal-title":"Rev Med Virol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0753-3322(99)80122-X","article-title":"HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes","volume":"53","author":"Le Buanec","year":"1999","journal-title":"Biomed Pharmacother"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4049\/jimmunol.167.1.497","article-title":"Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells","volume":"167","author":"Lee","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1074-7613(04)00380-2","article-title":"Interleukin-32: a cytokine and inducer of TNFalpha","volume":"2","author":"Kim","year":"2005","journal-title":"Immunity"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cyto.2009.03.007","article-title":"Molecular characterization of IL-32 in human endothelial cells","volume":"46","author":"Kobayashi","year":"2009","journal-title":"Cytokine"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1371\/journal.pmed.0030274","article-title":"IL-32: an emerging player in the immune response network against tuberculosis?","volume":"3","author":"Kundu","year":"2006","journal-title":"PLoS med"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar2074","article-title":"Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases","volume":"8","author":"Shoda","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"17868","DOI":"10.1074\/jbc.M900368200","article-title":"Interleukin-32 expression in the pancreas","volume":"284","author":"Nishida","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.200903-0400OC","article-title":"Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype","volume":"180","author":"Sorrentino","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.cellsig.2009.02.018","article-title":"Phospholipase A2-activating protein (PLAA) enhances cisplatin-induced apoptosis in HeLa cells","volume":"21","author":"Zhang","year":"2009","journal-title":"Cell Signal"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1073\/pnas.0600078103","article-title":"Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response","volume":"103","author":"Pett","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.181.1.557","article-title":"Endogenous IL-32 controls cytokine and HIV-1 production","volume":"181","author":"Nold","year":"2008","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.imlet.2008.01.007","article-title":"Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication","volume":"117","author":"Rasool","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"e1985","DOI":"10.1371\/journal.pone.0001985","article-title":"Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection","volume":"3","author":"Li","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB22|cit22","first-page":"429","article-title":"Cyclooxygenase-2 is overexpressed in human cervical cancer","volume":"7","author":"Kulkarni","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1525-1438.2006.00385.x","article-title":"Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas","volume":"16","author":"Chen","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1158\/0008-5472.CAN-06-4273","article-title":"Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor\/coactivator exchange","volume":"67","author":"Subbaramaiah","year":"2007","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-5793(01)02652-7","article-title":"Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18","volume":"501","author":"Cho","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB26|cit26","first-page":"1606","article-title":"Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining","volume":"18","author":"Seo","year":"2008","journal-title":"J Microbiol Biotechnol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1073\/pnas.0511233103","article-title":"IL-32, a proinflammatory cytokine in rheumatoid arthritis","volume":"103","author":"Joosten","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/pmic.200401106","article-title":"E7-expressing HaCaT keratinocyte cells are resistant to oxidative stress-induced cell death via the induction of catalase","volume":"5","author":"Shim","year":"2005","journal-title":"Proteomics"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","article-title":"Identification of the most active interleukin-32 isoform","volume":"126","author":"Choi","year":"2009","journal-title":"Immunology"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jim.2007.12.017","article-title":"Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA","volume":"333","author":"Kim","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0042-6822(92)90271-P","article-title":"Human papillomavirus type 16 expresses a variety of alternatively spliced mRNAs putatively encoding the E2 protein","volume":"191","author":"Sherman","year":"1992","journal-title":"Virology"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","article-title":"IL-32, a novel cytokine with a possible role in disease","volume":"65","author":"Dinarello","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ygyno.2004.08.036","article-title":"Expression of cyclooxygenase-2 in adenocarcinomas of the uterine cervix and its relation to angiogenesis and tumor growth","volume":"95","author":"Lee","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB34|cit34","first-page":"526","article-title":"Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance","volume":"29","author":"Luo","year":"2007","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11373-006-9114-6","article-title":"Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers","volume":"13","author":"Fujimoto","year":"2006","journal-title":"J Biomed Sci"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00262-008-0584-4","article-title":"High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells","volume":"58","author":"Herfs","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/JVI.63.3.1441-1447.1989","article-title":"Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms","volume":"63","author":"Smotkin","year":"1989","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10495-007-0163-8","article-title":"RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53","volume":"13","author":"Sima","year":"2008","journal-title":"Apoptosis"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ijc.2910500305","article-title":"Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers","volume":"50","author":"Sherman","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ygyno.2007.07.023","article-title":"COX-2 overexpression as a biomarker of early cervical carcinogenesis: a pilot study","volume":"107","author":"Saldivar","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1073\/pnas.0712391105","article-title":"Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function","volume":"105","author":"Marcondes","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/sj.onc.1206170","article-title":"Common fragile sites are preferential targets for HPV16 integrations in cervical tumors","volume":"22","author":"Thorland","year":"2003","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/rmv.488","article-title":"Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity","volume":"16","author":"Hebner","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/beog.2001.0213","article-title":"Human papillomavirus and cervical carcinogenesis","volume":"15","author":"Stanley","year":"2001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB45|cit45","first-page":"1108","article-title":"Induction of human cervical carcinoma by human papilloma virus and tumor promoters","volume":"82","author":"Cao","year":"2001","journal-title":"Zhonghua yi xue za zhi"},{"key":"10.1111\/j.1365-2567.2010.03377.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1002\/ijc.23837","article-title":"Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers","volume":"123","author":"Reuschenbach","year":"2008","journal-title":"Int J Cancer"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2567.2010.03377.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2567.2010.03377.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T06:25:15Z","timestamp":1625379915000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2567.2010.03377.x"}},"subtitle":["Feedback mechanism of IL-32 in HPV"],"short-title":[],"issued":{"date-parts":[[2011,1,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2567.2010.03377.x","relation":{},"ISSN":["0019-2805"],"issn-type":[{"value":"0019-2805","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,5]]}}}